2022 What's Next for Latin America Coagulation Testing Market?--Supplier Shares, Segment Forecasts, Opportunities in 22 Countries--Molecular, Chromogenic and Immunodiagnostic Hemostasis Tests--Growth Strategies, Latest Technologies, Instrumentation Pipeline
August 25, 2022
VPG Market Research
0
PDF
2022 What's Next for Latin America Coagulation Testing Market?--Supplier Shares, Segment Forecasts, Opportunities in 22 Countries--Molecular, Chromogenic and Immunodiagnostic Hemostasis Tests--Growth Strategies, Latest Technologies, Instrumentation Pipeline
Abstract
The report is available in Local PDF, Global PDF, and Data Pack formats (supplier shares, test volumes, sales forecasts). The report is delivered in both Excel and PDF.
This new 22-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.
The report explores business and technological trends; provides test volume and sales forecasts for 40 hemostasis procedures; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Rationale
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation diagnostics practice during the next five years.
New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
Coagulation Tests Analyzed in the Report
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.
Country Analyses
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Competitive Assessments
- Extensive strategic profiles of major suppliers and emerging market entrants.
Current and Emerging Products
- Review of established and emerging procedures.
- Comparison of automated and semi-automated analyzers marketed by Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.
Technology Review
- Analysis of current and emerging technologies and their potential market applications.
- Companies developing or marketing new technologies and products by test.
Strategic Recommendations
- Product development and business expansion opportunities with significant market appeal.
- Ideal product models with tentative prices and operating characteristics.
- Alternative market penetration strategies for instrument and reagent suppliers. - Potential market entry barriers and risks.
Content Table of Contents
I. Introduction II. Market Overview III. Major Product Development Opportunities IV. Design Criteria for Decentralized Testing Products V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Market and Technology Overview A. Major Routine and Special Coagulation Tests 1. Introduction 2. Activated Partial Thromboplastin Time (APTT) 3. Alpha-2 Antiplasmin 4. Antithrombin III 5. Bleeding Time 6. D-Dimer 7. Ethanol Flocculation Test 8. Euglobulin Lysis 9. Factor Assays a. Introduction b. Factor II c. Factor V/Factor V Leiden d. Factor VII e. Factor VIII f. Factor IX g. Factor IXa h. Factor X (Stuart Factor) i. Factor Xa j. Factor XI k. Factor XII l. Factor XIII 10. Fibrin Degradation Products 11. Fibrinogen 12. Heparin 13. Hirudin 14. Hypercoagulability and Thrombosis 15. Lipoprotein a 16. Plasmin 17. Plasminogen 18. Plasminogen Activator Inhibitor (PAI) 19. Platelet Function Tests 20. Platelet Aggregation 21. Proteins C and S 22. Prothrombin Fragment 1.2 23. Prothrombin Time (PT) 24. Reptilase Time 25. Thrombin Time 26. Tissue-Type Plasminogen Activator (t-PA) 27. Von Willebrand's Factor B. Coagulation Instrumentation Review: Centralized And POC Testing Analyzers C. Major Coagulation Testing Technologies And Their Potential Applications VIII. 22-Country Market Analyses: Market Size, Reagent and Instrument Sales Forecasts, Volume Projections for 40 Procedures, Supplier Sales and Market Shares IX. Competitive Assessments The report provides strategic assessments of over 20 leading coagulation market players and start-up companies with innovative technologies and products, including: Abbott Beckman Coulter/Danaher Becton Dickinson Diagnostica Stago Grifols Helena Laboratories IL/Werfen Roche Sekisui Diagnostics Siemens Healthineers Sysmex Thermo Fisher, and others List of Tables Argentina Coagulation Test Volume Forecasts by Procedure Argentina Coagulation Diagnostics Market by Product Category Bolivia Coagulation Test Volume Forecasts by Procedure Bolivia Coagulation Diagnostics Market by Product Category Brazil Coagulation Test Volume Forecasts by Procedure Brazil Coagulation Diagnostics Market by Product Category Chile Coagulation Test Volume Forecasts by Procedure Chile Coagulation Diagnostics Market by Product Category Colombia Coagulation Test Volume Forecasts by Procedure Colombia Coagulation Diagnostics Market by Product Category Costa Rica Coagulation Test Volume Forecasts by Procedure Costa Rica Coagulation Diagnostics Market by Product Category Cuba Coagulation Test Volume Forecasts by Procedure Cuba Coagulation Diagnostics Market by Product Category Dominican Republic Coagulation Test Volume Forecasts by Procedure Dominican Republic Coagulation Diagnostics Market by Product Category Ecuador Coagulation Test Volume Forecasts by Procedure Ecuador Coagulation Diagnostics Market by Product Category El Salvador Coagulation Test Volume Forecasts by Procedure El Salvador Coagulation Diagnostics Market by Product Category Guatemala Coagulation Test Volume Forecasts by Procedure Guatemala Coagulation Diagnostics Market by Product Category Haiti Coagulation Test Volume Forecasts by Procedure Haiti Coagulation Diagnostics Market by Product Category Honduras Coagulation Test Volume Forecasts by Procedure Honduras Coagulation Diagnostics Market by Product Category Jamaica Coagulation Test Volume Forecasts by Procedure Jamaica Coagulation Diagnostics Market by Product Category Mexico Coagulation Test Volume Forecasts by Procedure Mexico Coagulation Diagnostics Market by Product Category Nicaragua Coagulation Test Volume Forecasts by Procedure Nicaragua Coagulation Diagnostics Market by Product Category Panama Coagulation Test Volume Forecasts by Procedure Panama Coagulation Diagnostics Market by Product Category Paraguay Coagulation Test Volume Forecasts by Procedure Paraguay Coagulation Diagnostics Market by Product Category Peru Coagulation Test Volume Forecasts by Procedure Peru Coagulation Diagnostics Market by Product Category Puerto Rico Coagulation Test Volume Forecasts by Procedure Puerto Rico Coagulation Diagnostics Market by Product Category Uruguay Coagulation Test Volume Forecasts by Procedure Uruguay Coagulation Diagnostics Market by Product Category Venezuela Coagulation Test Volume Forecasts by Procedure Venezuela Coagulation Diagnostics Market by Product Category Major Companies Developing or Marketing Activated Clotting Time Tests Major Companies Developing or Marketing APTT Tests Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests Major Companies Developing or Marketing Antithrombin III Tests Major Companies Developing or Marketing Bleeding Time Tests Major Companies Developing or Marketing D-dimer Tests Major Companies Developing or Marketing Factor Assays Major Companies Developing or Marketing Fibrin Degradation Product Tests Major Companies Developing or Marketing Fibrinogen Tests Major Companies Developing or Marketing Heparin Tests Major Companies Developing or Marketing Plasmin Tests Major Companies Developing or Marketing Plasminogen Tests Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests Major Companies Developing or Marketing Platelet Aggregation Tests Major Companies Developing or Marketing Protein C Tests Major Companies Developing or Marketing Protein S Tests Major Companies Developing or Marketing PT Tests Major Companies Developing or Marketing Thrombin Time Tests Major Companies Developing or Marketing TPA Tests Major Companies Developing or Marketing Von Willebrand's Factor Tests
The report is available in Local PDF, Global PDF, and Data Pack formats (supplier shares, test volumes, sales forecasts). The report is delivered in both Excel and PDF.
This new 22-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.
The report explores business and technological trends; provides test volume and sales forecasts for 40 hemostasis procedures; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Rationale
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation diagnostics practice during the next five years.
New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
Coagulation Tests Analyzed in the Report
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.
Country Analyses
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Competitive Assessments
- Extensive strategic profiles of major suppliers and emerging market entrants.
Current and Emerging Products
- Review of established and emerging procedures.
- Comparison of automated and semi-automated analyzers marketed by Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.
Technology Review
- Analysis of current and emerging technologies and their potential market applications.
- Companies developing or marketing new technologies and products by test.
Strategic Recommendations
- Product development and business expansion opportunities with significant market appeal.
- Ideal product models with tentative prices and operating characteristics.
- Alternative market penetration strategies for instrument and reagent suppliers. - Potential market entry barriers and risks.
Table of Contents
I. Introduction II. Market Overview III. Major Product Development Opportunities IV. Design Criteria for Decentralized Testing Products V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Market and Technology Overview A. Major Routine and Special Coagulation Tests 1. Introduction 2. Activated Partial Thromboplastin Time (APTT) 3. Alpha-2 Antiplasmin 4. Antithrombin III 5. Bleeding Time 6. D-Dimer 7. Ethanol Flocculation Test 8. Euglobulin Lysis 9. Factor Assays a. Introduction b. Factor II c. Factor V/Factor V Leiden d. Factor VII e. Factor VIII f. Factor IX g. Factor IXa h. Factor X (Stuart Factor) i. Factor Xa j. Factor XI k. Factor XII l. Factor XIII 10. Fibrin Degradation Products 11. Fibrinogen 12. Heparin 13. Hirudin 14. Hypercoagulability and Thrombosis 15. Lipoprotein a 16. Plasmin 17. Plasminogen 18. Plasminogen Activator Inhibitor (PAI) 19. Platelet Function Tests 20. Platelet Aggregation 21. Proteins C and S 22. Prothrombin Fragment 1.2 23. Prothrombin Time (PT) 24. Reptilase Time 25. Thrombin Time 26. Tissue-Type Plasminogen Activator (t-PA) 27. Von Willebrand's Factor B. Coagulation Instrumentation Review: Centralized And POC Testing Analyzers C. Major Coagulation Testing Technologies And Their Potential Applications VIII. 22-Country Market Analyses: Market Size, Reagent and Instrument Sales Forecasts, Volume Projections for 40 Procedures, Supplier Sales and Market Shares IX. Competitive Assessments The report provides strategic assessments of over 20 leading coagulation market players and start-up companies with innovative technologies and products, including: Abbott Beckman Coulter/Danaher Becton Dickinson Diagnostica Stago Grifols Helena Laboratories IL/Werfen Roche Sekisui Diagnostics Siemens Healthineers Sysmex Thermo Fisher, and others List of Tables Argentina Coagulation Test Volume Forecasts by Procedure Argentina Coagulation Diagnostics Market by Product Category Bolivia Coagulation Test Volume Forecasts by Procedure Bolivia Coagulation Diagnostics Market by Product Category Brazil Coagulation Test Volume Forecasts by Procedure Brazil Coagulation Diagnostics Market by Product Category Chile Coagulation Test Volume Forecasts by Procedure Chile Coagulation Diagnostics Market by Product Category Colombia Coagulation Test Volume Forecasts by Procedure Colombia Coagulation Diagnostics Market by Product Category Costa Rica Coagulation Test Volume Forecasts by Procedure Costa Rica Coagulation Diagnostics Market by Product Category Cuba Coagulation Test Volume Forecasts by Procedure Cuba Coagulation Diagnostics Market by Product Category Dominican Republic Coagulation Test Volume Forecasts by Procedure Dominican Republic Coagulation Diagnostics Market by Product Category Ecuador Coagulation Test Volume Forecasts by Procedure Ecuador Coagulation Diagnostics Market by Product Category El Salvador Coagulation Test Volume Forecasts by Procedure El Salvador Coagulation Diagnostics Market by Product Category Guatemala Coagulation Test Volume Forecasts by Procedure Guatemala Coagulation Diagnostics Market by Product Category Haiti Coagulation Test Volume Forecasts by Procedure Haiti Coagulation Diagnostics Market by Product Category Honduras Coagulation Test Volume Forecasts by Procedure Honduras Coagulation Diagnostics Market by Product Category Jamaica Coagulation Test Volume Forecasts by Procedure Jamaica Coagulation Diagnostics Market by Product Category Mexico Coagulation Test Volume Forecasts by Procedure Mexico Coagulation Diagnostics Market by Product Category Nicaragua Coagulation Test Volume Forecasts by Procedure Nicaragua Coagulation Diagnostics Market by Product Category Panama Coagulation Test Volume Forecasts by Procedure Panama Coagulation Diagnostics Market by Product Category Paraguay Coagulation Test Volume Forecasts by Procedure Paraguay Coagulation Diagnostics Market by Product Category Peru Coagulation Test Volume Forecasts by Procedure Peru Coagulation Diagnostics Market by Product Category Puerto Rico Coagulation Test Volume Forecasts by Procedure Puerto Rico Coagulation Diagnostics Market by Product Category Uruguay Coagulation Test Volume Forecasts by Procedure Uruguay Coagulation Diagnostics Market by Product Category Venezuela Coagulation Test Volume Forecasts by Procedure Venezuela Coagulation Diagnostics Market by Product Category Major Companies Developing or Marketing Activated Clotting Time Tests Major Companies Developing or Marketing APTT Tests Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests Major Companies Developing or Marketing Antithrombin III Tests Major Companies Developing or Marketing Bleeding Time Tests Major Companies Developing or Marketing D-dimer Tests Major Companies Developing or Marketing Factor Assays Major Companies Developing or Marketing Fibrin Degradation Product Tests Major Companies Developing or Marketing Fibrinogen Tests Major Companies Developing or Marketing Heparin Tests Major Companies Developing or Marketing Plasmin Tests Major Companies Developing or Marketing Plasminogen Tests Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests Major Companies Developing or Marketing Platelet Aggregation Tests Major Companies Developing or Marketing Protein C Tests Major Companies Developing or Marketing Protein S Tests Major Companies Developing or Marketing PT Tests Major Companies Developing or Marketing Thrombin Time Tests Major Companies Developing or Marketing TPA Tests Major Companies Developing or Marketing Von Willebrand's Factor Tests